Majid Muhammad, Agrawal Ankit, Daniela Arockiam Aro, Rosenzveig Akiva, Kumar Ashwin, Singh Bhalla Jaideep, Asghar Muhammad Sohaib, Shimshak Thomas, Brands Chad, Klein Allan L
Center for Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Internal Medicine, AdventHealth Sebring, Sebring, Florida, USA.
JACC Case Rep. 2024 Oct 2;29(19):102570. doi: 10.1016/j.jaccas.2024.102570.
A 69-year-old man presented with corticosteroid-dependent colchicine-resistant chronic recurrent pericarditis initially thought to be idiopathic in etiology. Transitioning from anakinra to rilonacept revealed rheumatoid arthritis as the underlying cause. Anakinra demonstrated superior efficacy in managing both pericarditis and rheumatoid arthritis symptoms.
一名69岁男性患者,患有依赖皮质类固醇且对秋水仙碱耐药的慢性复发性心包炎,病因最初被认为是特发性的。从阿那白滞素转换为利罗那肽后发现潜在病因是类风湿关节炎。阿那白滞素在控制心包炎和类风湿关节炎症状方面显示出更好的疗效。